"10.1371_journal.pone.0044891","none","2012-09-14T00:00:00Z","Michael Rudnicki; Paul Perco; Hannes Neuwirt; Susie-Jane Noppert; Johannes Leierer; Judith Sunzenauer; Susanne Eder; Carlamaria Zoja; Kathrin Eller; Alexander R Rosenkranz; Gerhard A Müller; Bernd Mayer; Gert Mayer","Medical University Innsbruck, Deptartment of Internal Medicine IV - Nephrology and Hypertension, Innsbruck, Austria; Emergentec Biodevelopment GmbH, Vienna, Austria; Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy; Medical University of Graz, Deptartment of Internal Medicine, Clinical Division of Nephrology and Hemodialysis, Graz, Austria; Georg-August-University Göttingen, Department of Medicine, Nephrology and Rheumatology, Göttingen, Germany","Conceived and designed the experiments: MR PP BM GM. Performed the experiments: MR HN SJN JS SE KE JL. Analyzed the data: MR PP. Contributed reagents/materials/analysis tools: HN KE ARR GAM CZ. Wrote the paper: MR PP GM.","MR, PP, and GM filed a patent application on versican for prediction of progressive nephropathy in CKD patients (PCT/EP2010/057917: A method of diagnosing renal disorders). BM is co-owner, and PP is employee of emergentec biodevelopment GmbH. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. All other authors have nothing to disclose.","2012","09","Michael Rudnicki","MR",13,TRUE,4,7,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
